Ageing with HIV in South Africa
We used an established microsimulation model, quantified to a rural South African setting with a well developed antiretroviral treatment programme, to predict the impact of antiretroviral therapy on the HIV epidemic in the population aged over 50 years. We show that the HIV prevalence in patients ag...
Gespeichert in:
Veröffentlicht in: | AIDS (London) 2011-08, Vol.25 (13), p.1665-1667 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1667 |
---|---|
container_issue | 13 |
container_start_page | 1665 |
container_title | AIDS (London) |
container_volume | 25 |
creator | HONTELEZ, Jan A. C LURIE, Mark N NEWELL, Marie-Louise BAKKER, Roel TANSER, Frank BARNIGHAUSEN, Till BALTUSSEN, Rob DE VLAS, Sake J |
description | We used an established microsimulation model, quantified to a rural South African setting with a well developed antiretroviral treatment programme, to predict the impact of antiretroviral therapy on the HIV epidemic in the population aged over 50 years. We show that the HIV prevalence in patients aged over 50 years will nearly double in the next 30 years, whereas the fraction of HIV-infected patients aged over 50 years will triple in the same period. This ageing epidemic has important consequences for the South African healthcare system, as older HIV patients require specialized care. |
doi_str_mv | 10.1097/QAD.0b013e32834982ea |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3886337</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>890679787</sourcerecordid><originalsourceid>FETCH-LOGICAL-c437t-f0e88d39bf8600608843c12ac12a9489689f5db9dd67d8998994cf0079403e8f3</originalsourceid><addsrcrecordid>eNpdkdtLwzAUxoMobk7_A9G9iE_VkybN5UUo87LBQMTLa0jTZIt07Wxaxf_ejs15gRMOh_zO94UvCB1juMAg-eVDen0BGWBiSSwIlSK2egf1MeUkShKOd1EfYiYjSTj00EEIrwCQgBD7qBdjJjAkrI9O05n15Wz44Zv5cDx5Gfpy-Fi13ZC62ht9iPacLoI92vQBer69eRqNo-n93WSUTiNDCW8iB1aInMjMCQbAOhdKDI716kgqJBPSJXkm85zxXEjZFTUOgEsKxApHBuhqrbtss4XNjS2bWhdqWfuFrj9Vpb36e1P6uZpV74oIwQjhncD5RqCu3lobGrXwwdii0KWt2qCEBMYlFyuSrklTVyHU1m1dMKhVtKqLVv2Ptls7-f3C7dJ3lh1wtgF0MLpwtS6NDz8c7X6GJZh8AXW1gH0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>890679787</pqid></control><display><type>article</type><title>Ageing with HIV in South Africa</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>HONTELEZ, Jan A. C ; LURIE, Mark N ; NEWELL, Marie-Louise ; BAKKER, Roel ; TANSER, Frank ; BARNIGHAUSEN, Till ; BALTUSSEN, Rob ; DE VLAS, Sake J</creator><creatorcontrib>HONTELEZ, Jan A. C ; LURIE, Mark N ; NEWELL, Marie-Louise ; BAKKER, Roel ; TANSER, Frank ; BARNIGHAUSEN, Till ; BALTUSSEN, Rob ; DE VLAS, Sake J</creatorcontrib><description>We used an established microsimulation model, quantified to a rural South African setting with a well developed antiretroviral treatment programme, to predict the impact of antiretroviral therapy on the HIV epidemic in the population aged over 50 years. We show that the HIV prevalence in patients aged over 50 years will nearly double in the next 30 years, whereas the fraction of HIV-infected patients aged over 50 years will triple in the same period. This ageing epidemic has important consequences for the South African healthcare system, as older HIV patients require specialized care.</description><identifier>ISSN: 0269-9370</identifier><identifier>EISSN: 1473-5571</identifier><identifier>DOI: 10.1097/QAD.0b013e32834982ea</identifier><identifier>PMID: 21681056</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins</publisher><subject>Adult ; Aged ; Anti-HIV Agents - therapeutic use ; Biological and medical sciences ; Delivery of Health Care - trends ; Female ; Forecasting ; HIV Infections - epidemiology ; Human viral diseases ; Humans ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunopathology ; Infectious diseases ; Male ; Medical sciences ; Middle Aged ; Models, Theoretical ; Population Dynamics ; Prevalence ; Risk Factors ; Risk-Taking ; Rural Health - trends ; Rural Population ; South Africa - epidemiology ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids</subject><ispartof>AIDS (London), 2011-08, Vol.25 (13), p.1665-1667</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c437t-f0e88d39bf8600608843c12ac12a9489689f5db9dd67d8998994cf0079403e8f3</citedby><cites>FETCH-LOGICAL-c437t-f0e88d39bf8600608843c12ac12a9489689f5db9dd67d8998994cf0079403e8f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24473651$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21681056$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HONTELEZ, Jan A. C</creatorcontrib><creatorcontrib>LURIE, Mark N</creatorcontrib><creatorcontrib>NEWELL, Marie-Louise</creatorcontrib><creatorcontrib>BAKKER, Roel</creatorcontrib><creatorcontrib>TANSER, Frank</creatorcontrib><creatorcontrib>BARNIGHAUSEN, Till</creatorcontrib><creatorcontrib>BALTUSSEN, Rob</creatorcontrib><creatorcontrib>DE VLAS, Sake J</creatorcontrib><title>Ageing with HIV in South Africa</title><title>AIDS (London)</title><addtitle>AIDS</addtitle><description>We used an established microsimulation model, quantified to a rural South African setting with a well developed antiretroviral treatment programme, to predict the impact of antiretroviral therapy on the HIV epidemic in the population aged over 50 years. We show that the HIV prevalence in patients aged over 50 years will nearly double in the next 30 years, whereas the fraction of HIV-infected patients aged over 50 years will triple in the same period. This ageing epidemic has important consequences for the South African healthcare system, as older HIV patients require specialized care.</description><subject>Adult</subject><subject>Aged</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Delivery of Health Care - trends</subject><subject>Female</subject><subject>Forecasting</subject><subject>HIV Infections - epidemiology</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Models, Theoretical</subject><subject>Population Dynamics</subject><subject>Prevalence</subject><subject>Risk Factors</subject><subject>Risk-Taking</subject><subject>Rural Health - trends</subject><subject>Rural Population</subject><subject>South Africa - epidemiology</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><issn>0269-9370</issn><issn>1473-5571</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkdtLwzAUxoMobk7_A9G9iE_VkybN5UUo87LBQMTLa0jTZIt07Wxaxf_ejs15gRMOh_zO94UvCB1juMAg-eVDen0BGWBiSSwIlSK2egf1MeUkShKOd1EfYiYjSTj00EEIrwCQgBD7qBdjJjAkrI9O05n15Wz44Zv5cDx5Gfpy-Fi13ZC62ht9iPacLoI92vQBer69eRqNo-n93WSUTiNDCW8iB1aInMjMCQbAOhdKDI716kgqJBPSJXkm85zxXEjZFTUOgEsKxApHBuhqrbtss4XNjS2bWhdqWfuFrj9Vpb36e1P6uZpV74oIwQjhncD5RqCu3lobGrXwwdii0KWt2qCEBMYlFyuSrklTVyHU1m1dMKhVtKqLVv2Ptls7-f3C7dJ3lh1wtgF0MLpwtS6NDz8c7X6GJZh8AXW1gH0</recordid><startdate>20110824</startdate><enddate>20110824</enddate><creator>HONTELEZ, Jan A. C</creator><creator>LURIE, Mark N</creator><creator>NEWELL, Marie-Louise</creator><creator>BAKKER, Roel</creator><creator>TANSER, Frank</creator><creator>BARNIGHAUSEN, Till</creator><creator>BALTUSSEN, Rob</creator><creator>DE VLAS, Sake J</creator><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20110824</creationdate><title>Ageing with HIV in South Africa</title><author>HONTELEZ, Jan A. C ; LURIE, Mark N ; NEWELL, Marie-Louise ; BAKKER, Roel ; TANSER, Frank ; BARNIGHAUSEN, Till ; BALTUSSEN, Rob ; DE VLAS, Sake J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c437t-f0e88d39bf8600608843c12ac12a9489689f5db9dd67d8998994cf0079403e8f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Delivery of Health Care - trends</topic><topic>Female</topic><topic>Forecasting</topic><topic>HIV Infections - epidemiology</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Models, Theoretical</topic><topic>Population Dynamics</topic><topic>Prevalence</topic><topic>Risk Factors</topic><topic>Risk-Taking</topic><topic>Rural Health - trends</topic><topic>Rural Population</topic><topic>South Africa - epidemiology</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HONTELEZ, Jan A. C</creatorcontrib><creatorcontrib>LURIE, Mark N</creatorcontrib><creatorcontrib>NEWELL, Marie-Louise</creatorcontrib><creatorcontrib>BAKKER, Roel</creatorcontrib><creatorcontrib>TANSER, Frank</creatorcontrib><creatorcontrib>BARNIGHAUSEN, Till</creatorcontrib><creatorcontrib>BALTUSSEN, Rob</creatorcontrib><creatorcontrib>DE VLAS, Sake J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>AIDS (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HONTELEZ, Jan A. C</au><au>LURIE, Mark N</au><au>NEWELL, Marie-Louise</au><au>BAKKER, Roel</au><au>TANSER, Frank</au><au>BARNIGHAUSEN, Till</au><au>BALTUSSEN, Rob</au><au>DE VLAS, Sake J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ageing with HIV in South Africa</atitle><jtitle>AIDS (London)</jtitle><addtitle>AIDS</addtitle><date>2011-08-24</date><risdate>2011</risdate><volume>25</volume><issue>13</issue><spage>1665</spage><epage>1667</epage><pages>1665-1667</pages><issn>0269-9370</issn><eissn>1473-5571</eissn><abstract>We used an established microsimulation model, quantified to a rural South African setting with a well developed antiretroviral treatment programme, to predict the impact of antiretroviral therapy on the HIV epidemic in the population aged over 50 years. We show that the HIV prevalence in patients aged over 50 years will nearly double in the next 30 years, whereas the fraction of HIV-infected patients aged over 50 years will triple in the same period. This ageing epidemic has important consequences for the South African healthcare system, as older HIV patients require specialized care.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins</pub><pmid>21681056</pmid><doi>10.1097/QAD.0b013e32834982ea</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0269-9370 |
ispartof | AIDS (London), 2011-08, Vol.25 (13), p.1665-1667 |
issn | 0269-9370 1473-5571 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3886337 |
source | MEDLINE; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals |
subjects | Adult Aged Anti-HIV Agents - therapeutic use Biological and medical sciences Delivery of Health Care - trends Female Forecasting HIV Infections - epidemiology Human viral diseases Humans Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Infectious diseases Male Medical sciences Middle Aged Models, Theoretical Population Dynamics Prevalence Risk Factors Risk-Taking Rural Health - trends Rural Population South Africa - epidemiology Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids |
title | Ageing with HIV in South Africa |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T23%3A37%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ageing%20with%20HIV%20in%20South%20Africa&rft.jtitle=AIDS%20(London)&rft.au=HONTELEZ,%20Jan%20A.%20C&rft.date=2011-08-24&rft.volume=25&rft.issue=13&rft.spage=1665&rft.epage=1667&rft.pages=1665-1667&rft.issn=0269-9370&rft.eissn=1473-5571&rft_id=info:doi/10.1097/QAD.0b013e32834982ea&rft_dat=%3Cproquest_pubme%3E890679787%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=890679787&rft_id=info:pmid/21681056&rfr_iscdi=true |